We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602,... ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. Show more
LAUSANNE, Switzerland, May 15, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the...
LAUSANNE, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the...
LAUSANNE, Switzerland, May 06, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it has agreed to sell, by way of an underwritten offering, 13,411,912 of its common...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.32 | -7.76699029126 | 4.12 | 4.32 | 3.67 | 543634 | 3.96570451 | CS |
4 | -1.19 | -23.8476953908 | 4.99 | 5.17 | 3.67 | 610204 | 4.36214396 | CS |
12 | -1.25 | -24.7524752475 | 5.05 | 5.38 | 3.23 | 565217 | 4.49523129 | CS |
26 | 3.0569 | 411.371282465 | 0.7431 | 6.04 | 0.6883 | 753741 | 3.28697812 | CS |
52 | 1.22 | 47.2868217054 | 2.58 | 6.04 | 0.359908 | 566216 | 2.63771129 | CS |
156 | -16.78 | -81.5354713314 | 20.58 | 32 | 0.359908 | 431251 | 6.15127047 | CS |
260 | -26.2 | -87.3333333333 | 30 | 56.5899 | 0.359908 | 388411 | 10.61927664 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions